CN103142693A - Superfine powdery Chinese medicinal preparation for treating allergic rhinitis - Google Patents
Superfine powdery Chinese medicinal preparation for treating allergic rhinitis Download PDFInfo
- Publication number
- CN103142693A CN103142693A CN2013100921774A CN201310092177A CN103142693A CN 103142693 A CN103142693 A CN 103142693A CN 2013100921774 A CN2013100921774 A CN 2013100921774A CN 201310092177 A CN201310092177 A CN 201310092177A CN 103142693 A CN103142693 A CN 103142693A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- herba
- chinese medicinal
- allergic rhinitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention relates to a superfine powdery Chinese medicinal preparation for treating allergic rhinitis. The superfine powdery Chinese medicinal preparation is prepared from the following Chinese medicinal herbs: 14-25 parts of centipeda minima, 14-25 parts of astragalus, 8-15 parts of roasted rhizoma atractylodis macrocephalae, 8-15 parts of cicada slough, 5-15 parts of angelica, 5-15 parts of saposhnikovia divaricata, 5-15 parts of cocklebur, 5-15 parts of mint, 1-10 parts of licorice, 0.5-5 parts of asarum and 0.1-2.0 parts of borneol. The superfine powdery Chinese medicinal preparation is prepared according to the following steps of: grinding all the Chinese medicinal herbs into superfine powder with the particle size of 25-74mu m or smaller, mixing the superfine powder uniformly, and packaging the superfine powder according to the one-time therapeutic dose. The superfine powdery Chinese medicinal preparation is used for treating allergic rhinitis, has the advantages of directly eliminating the local sensitizing factor, promoting the metabolism and the regeneration of the nasal mucosa, repairing the damaged nasal mucosa, reducing the release of the allergic mediator, reducing the activity of the allergic mediator, forming a protective film on the surface of the allergic mediator and strengthening the endothelial cell and the smooth muscle cell to improve the adaptability of the nasal mucosa to external allergens.
Description
Technical field
The invention belongs to the ultramicro powder Chinese medicine category, be specifically related to a kind of ultramicro powder Chinese medicine for the treatment of of allergic rhinitis.
Background technology
The Epidemiological study of recent two decades shows, the sickness rate of allergic rhinitis obviously rises, and generally increases 5～10 times, and the sickness rate of China's anaphylactic disease surpasses 20%, certain areas have even surpassed 30%, and medical expense also accounts for the second of otorhinolaryngology disease series.Allergic rhinitis can betide any age bracket crowd, and the Most patients age less than 20 years old, is a commonly encountered diseases.According to domestic document announcement, nearly 10% child and 20% teenager suffer from perennial rhinitis, wherein mostly are greatly allergy.Approximately 75% asthmatic children also has primary disease.Because nasal cavity stops up, the patient has to breathe with the oral cavity, and the anaphylactogen that therefore directly sucks from the oral cavity is more, thereby asthma is increased the weight of.
If allergic rhinitis can not get timely treatment, be easy to bring out adjacent organs generation pathological changes in the process of morbidity.Allergic rhinitis and allergic asthma are in close relations, and most of asthma patients are with allergic rhinitis.In addition, allergic rhinitis also can cause the complication such as sinusitis, nasal polyp, deviation of nasal septum, olfactory nerves forfeiture, suffers from allergic rhinitis and must reach early treatment, otherwise can injure all, and involves other organ generation pathological changes, impact normal operation and life.
Summary of the invention
The application's goal of the invention is to provide a kind of ultramicro powder Chinese medicine for the treatment of of allergic rhinitis.
The application's technical scheme is the ultramicro powder Chinese medicine of a kind for the treatment of of allergic rhinitis of development, it is characterized in that:
⑴ made by the Chinese medicine of following weight proportion
14～25 parts of Herba Centipedae, 14～25 parts of the Radixs Astragali, 8～15 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 8～15 parts of Periostracum Cicadaes, 5～15 parts of the Radixs Angelicae Dahuricae, 5～15 parts of Radix Saposhnikoviaes, 5～15 parts of Fructus Xanthii, 5～15 parts of Herba Menthaes, 1～10 part, Radix Glycyrrhizae, 0.1～2.0 part of 0.5～5 part of Herba Asari and Borneolum Syntheticum;
⑵ the preparation method of described ultramicro powder Chinese medicine is characterized in that comprising the steps
1. after the Chinese crude drug of above-mentioned dosage being cleaned, be ground into respectively the micropowders of particle diameter≤74～25 μ m;
2. pack respectively by each treatment by Chinese herbs dosage, standby;
3. each Chinese medicine micropowders mix homogeneously that will pack is respectively packed separately by seance dosage;
⑶ the application of described ultramicro powder Chinese medicine is characterized in that the application in the pharmaceutical preparation of preparation treatment of allergic rhinitis.
Above-mentioned ultramicro powder Chinese medicine is characterized in that and can be made by the Chinese medicine of following weight proportion:
16～22 parts of Herba Centipedae, 16～22 parts of the Radixs Astragali, 10～13 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 10～13 parts of Periostracum Cicadaes, 12～15 parts of the Radixs Angelicae Dahuricae, 9～12 parts of Radix Saposhnikoviaes, 9～12 parts of Fructus Xanthii, 9～12 parts of Herba Menthaes, 4～8 parts, Radix Glycyrrhizae, 0.8～1.5 part of 1～3 part of Herba Asari and Borneolum Syntheticum.
Above-mentioned ultramicro powder Chinese medicine is characterized in that also can being made by the Chinese medicine of following weight proportion:
18～20 parts of Herba Centipedae, 18～20 parts of the Radixs Astragali, 11～12 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 11～12 parts of Periostracum Cicadaes, 9～12 parts of the Radixs Angelicae Dahuricae, 8～10 parts of Radix Saposhnikoviaes, 7～9 parts of Fructus Xanthii, 5～8 parts of Herba Menthaes, 3～4 parts, Radix Glycyrrhizae, 1.5～2.0 parts of 2～2.5 parts of Herba Asaris and Borneolum Syntheticums.
Allergic rhinitis are a kind of allergy that occur in nasal mucosa, and it is its main feature that the nasal mucosa sensitivity increases, and can cause multiple complications.Primary disease has dividing of long-term property and seasonality, is one of refractory disease clinically.Allergic rhinitis whole world average attack rate though itself is not serious disease, has a strong impact on Quality of Life, and can bring out bronchial asthma, sinusitis, nasal polyp, otitis media, or occur simultaneously with allergic conjunctivitis 10%～25%.Therefore, the active treatment allergic rhinitis are also the prerequisites of other diseases of blocking-up.
In prior art, doctor trained in Western medicine adopts the Therapeutic Method such as antihistamine drug, glucocorticoid, specific active immunotherapy, microwave and operation more.Though method is many, reach healing very difficult, the untoward reaction of medicine is also to can not be ignored problem simultaneously.
Allergic rhinitis belong to the traditional Chinese medical science " allergic rhinitis " category, sick position is at nose, a kind of common, multiple cacorhinia take rhinocnesmus unexpected and outbreak repeatedly, sneeze, snivel, nasal obstruction etc. as feature, closely related with lung, spleen, kidney, pathogenesis mainly is classified as lung, spleen, kidney three deficiency of five ZANG-organs damages, official report matter is special, being invaded by exogenous pathogen unusual pathogen and causing a disease.
According to theory of Chinese medical science, the Therapeutic Principle of allergic rhinitis: clear the nasal passage, expelling wind and removing dampness consolidates convergence, antiallergic, heat clearing away poison, righting gas.
The application is the ultramicro powder Chinese medicine that Effective Component of Chinese Medicine is made, and its fineness meets and exceeds the requirement of " impalpable powder " in existing pharmacopeia, and its therapeutic effect has qualitative leap.Directly remove sensitizing factor by nasil, promote the metabolism of nasal mucosa, promote nasal mucosa regeneration, repair the nasal mucosa damage, reduce the release of anaphylaxis medium, make activity decreased, and form protecting film on its surface.Can strengthen endotheliocyte, smooth muscle cell.Reach the adaptive capacity in sensitization source to external world.The effect of its performance has two aspects: one. and directly act on focus, permeates cell membranes is eliminated sensitizer, and the symptoms such as rhinocnesmus, watery nasal discharge, sneeze go to well and fade away.The sensitizing factor of getting rid of nasal cavity is eliminated the nasal mucosa endomycin, repairs impaired nose mucosa, and olfactory sensation is to improving; Two. nasal cavity obviously improves the immunity of anaphylactogen, and the sensitivity response after the contact allergy material becomes slow, and the resistance of anaphylactogen is strengthened to external world.
Advantage of the present invention:
1. sensitizing factor is directly removed in the part, promotes the metabolism of nasal mucosa, promotes nasal mucosa regeneration, and the damage of reparation nasal mucosa reduces the release of allergia medium, makes activity decreased, and forms protecting film on its surface.Can strengthen endotheliocyte, smooth muscle cell.Reach the adaptive capacity in sensitization source to external world.
2. the preparation standard of the application's preparation is unified, meets Chinese medicine standardization, standardization, scientific management expectancy.
3. be Noninvasive therapy during the application's formulation application, effect is remarkable, and cure rate is high, and relapse rate is low, the few and environmental protection of dosage, easy to use and flexible.
The specific embodiment
Below in conjunction with embodiment, the application is further elaborated
Embodiment 1:
Adopt Chinese crude drug to be the Chinese crude drug that existing pharmacopeia is recorded, use commercially available super micron mill (cell wall breaking) sporoderm-broken rate high, the micropowders (meeting and exceeding the requirement of " impalpable powder " in existing pharmacopeia) of grain size of micropowder≤74～25 μ m after Chinese crude drug processing.
Proportioning: Herba Centipedae 25g, Radix Astragali 25g, Rhizoma Atractylodis Macrocephalae (parched) 15g, Periostracum Cicadae 15g, Radix Angelicae Dahuricae 15g, Radix Saposhnikoviae 15g part, Fructus Xanthii 15g, Herba Menthae 15g, Radix Glycyrrhizae 10g, Herba Asari 5g and Borneolum Syntheticum 2.0g;
Preparation method:
1. after the Chinese crude drug of above-mentioned dosage being cleaned, be ground into respectively the micropowders of particle diameter≤74～25 μ m;
2. pack respectively by each treatment by Chinese herbs dosage, standby;
3. each Chinese medicine micropowders mix homogeneously that will pack is respectively packed separately by seance dosage;
Use: the application in the pharmaceutical preparation of preparation treatment of allergic rhinitis.
The applicant puts into nasal cavity by clinical research and observation with the application's preparation, can directly remove sensitizing factor, repairs impaired nasal mucosa, activates the nasal cavity immunity function, and the normal nasal mucosa tissue of regenerating is difficult for recurrence after treatment.This treatment is without wound, and no pain without relying on, does not affect work and study, is the effective therapy of a kind of uniqueness for the treatment of allergic rhinitis.
2009～2011 years applicant's out-patient treatment patient 125 examples, male 50 examples wherein, female's 75 examples; 15～60 years old age, 34.53 years old mean age.
Inclusive criteria
1. 15～60 years old age, male or female; 2. meet long-term diagnosis of allergic rhinitis standard, be in typical case's stage of attack; 3. do not accept antihistamine drug treatment in 3d, and the person that do not take the 17-hydroxy-11-dehydrocorticosterone in 2 weeks, can the partner treatment plan.
Main exclusion standard
1. be associated with the primary diseases such as the serious heart, liver, kidney, cerebrovascular; 2. psychotic; 3. gestation or women breast-feeding their children, plan the men and women of fertility in the recent period; 4. Chinese medicine used there is allergy sufferers; 5. be engaged in the work of attention high concentration, as driver, work high above the ground person.
Pharmaceutical preparation and application
Get preparation and the good Chinese medicine micropowders 1g of mixing during treatment, wrap the Chinese medicine micropowders with the absorbent cotton thin slice, fill in the Ipsilateral nasal cavity and (be Ipsilateral as the both sides nasal cavity, alternatively administered during treatment.), (Chinese medicine micropowders) absorbent cotton bag is at every turn Ipsilateral nasal cavity reservation 20～30 minutes, and one day 1～2 time (preferably morning, evening are respectively once) intermittently gone after per course for the treatment of and treated 15 days courses for the treatment of in three days again, estimated after three courses for the treatment of.
Estimate and standard
The symptom evaluation criterion
The classification of symptom scoring criteria
Annotate:
★1 continuous sneeze number;
★ ★Every day the blowing the nose number of times
The sign evaluation criterion
At the bottom of concha nasalis inferior and nose, nasal septum near, can not see middle nasal concha, or middle nasal concha mucosa Polypoid changes, polyp form, be recorded as 3 minutes;
Concha nasalis inferior and nasal septum (or at the bottom of nose) near, small gap is still arranged between (or nasal septum) at the bottom of concha nasalis inferior and nose, be recorded as 2 minutes;
Still as seen concha nasalis mild swelling, nasal septum, middle nasal concha are recorded as 1 minute.
Criterion of therapeutical effect
Score standard with reference to Chinese Journal of Otorhinolaryngology Head And Neck Surgery editorial board, hals,Nasen und Ohrenheilkunde branch of Chinese Medical Association " principle of diagnosis and treatment of allergic rhinitis and suggested design (2004, Lanzhou) ".According to the sings and symptoms evaluation curative effect of scoring, scoring system:
Improvement rate 〉=66% is produce effects; Improvement rate 〉=26% ,≤65% be effective; Improvement rate≤25% is invalid.
Therapeutic outcome
The application is applied to treatment of allergic rhinitis after three courses for the treatment of, total effective rate: 88.8%; Obvious effective rate 48.0%; Effective percentage 40.8%; Inefficiency 11.2%.
Clinical verification shows: the application is applied to treatment of allergic rhinitis, can effectively prevent and treat long-term allergic rhinitis, the ability of enhancing body opposing pathogenic factor, curative effect is obvious, have easy and simple to handle, safe and effective, without wound, all-ages characteristics, clinic is promoted.
Model case:
1. patient Lee XX, man, 53 years old, the symptoms such as both sides rhinocnesmus, persistence sneeze, clear water sample tears, nasal obstruction occur for a long time, with the spring and autumn performance obviously, 2009 medical, meet the diagnosis of allergic rhinitis standard, get rid of other health illness, the patient accepts this Therapeutic Method.Get during treatment and prepare ultrafine powder traditional Chinese medicine 1 gram, fill in the Ipsilateral nasal cavity with cotton sheet parcel, both sides alternatively administered during treatment, each 20～30 minutes, one day 1～2 time, after 15 days courses for the treatment of, patient's symptom obviously alleviates, and sneeze, thin nasal discharge reduce, and nasal obstruction is eliminated substantially, after treating again two courses for the treatment of, be significant curative effect by evaluation criterion.
2. patient river XX, the man, 44 years old, suffered from allergic rhinitis 3 years, once used multiple Drug therapy, still outbreak repeatedly, have a strong impact on Quality of Life, reduces under work efficiency, also brings out occasionally simultaneously asthma, occurs breathing heavily the symptom such as suppressing, uncomfortable in chest.Medical over 2010, have the attitude of trying in arms and accept this Therapeutic Method.The patient meets the diagnosis of allergic rhinitis standard after diagnosing, gets rid of other health illness.Get during treatment and prepare ultrafine powder traditional Chinese medicine 1 gram, fill in the Ipsilateral nasal cavity with cotton sheet parcel, both sides alternatively administered during treatment, each 20～30 minutes, one day 1～2 time, after two course of therapy, patient's symptom obviously alleviates, and sneeze, thin nasal discharge reduce, and has a stuffy nose, breathes heavily and the symptom such as suppress and substantially eliminate, after treating again a course for the treatment of, be significant curative effect by evaluation criterion.
3. patient king X, the female, 39 years old, seasonal outbreak allergic rhinitis over nearly 3 years, increased the weight of gradually, affect Quality of Life, and the work efficiency reduction is depressed, anxious state of mind.Medical over 2011, accept voluntarily this Therapeutic Method, the patient meets the diagnosis of allergic rhinitis standard after diagnosing, gets rid of other health illness.Get during treatment and prepare ultrafine powder traditional Chinese medicine 1 gram, fill in the Ipsilateral nasal cavity, both sides alternatively administered during treatment, each 20～30 minutes with cotton sheet parcel, one day 1～2 time, after a course of therapy, patient's symptom obviously alleviates, and sneeze, thin nasal discharge reduce, nasal obstruction is basic to be eliminated, patient's heart clearing heat in QI system is refreshing, then after treating two courses for the treatment of, clinical cure.
4. the patient opens X, the man, and 17 years old, sneeze, thin nasal discharge repeatedly occurred after catching a cold spring, the symptoms such as nasal obstruction, the learning efficiency obviously descends, and mood is irritated.Medical over 2010, accept voluntarily this Therapeutic Method, the patient meets the diagnosis of allergic rhinitis standard after diagnosing, gets rid of other health illness.Get during treatment and prepare ultrafine powder traditional Chinese medicine 1 gram, fill in Ipsilateral side nasal cavity with cotton sheet parcel, both sides alternatively administered during treatment, each 20～30 minutes, one day 1～2 time, after a course of therapy, patient's symptom was eliminated substantially, and the learning efficiency obviously improves, clinical cure.
5. patient Xing XX, the female, 23 years old, because learning fatigue, the symptoms such as sneeze, thin nasal discharge, nasal obstruction appear after flu repeatedly, and the learning efficiency is lower the reduction obviously.Medical over 2011, the patient meets the diagnosis of allergic rhinitis standard after diagnosing, gets rid of other health illness, accept this Therapeutic Method, get during treatment and prepare ultrafine powder traditional Chinese medicine 1 gram, fill in the Ipsilateral nasal cavity, both sides alternatively administered during treatment with cotton sheet parcel, each 20～30 minutes, one day 1～2 time, after two course of therapy, patient's symptom is eliminated substantially, the learning efficiency obviously improves, clinical cure.
Embodiment 2
Proportioning: Herba Centipedae 18g, Radix Astragali 20g, Rhizoma Atractylodis Macrocephalae (parched) 11g, Periostracum Cicadae 12g, Radix Angelicae Dahuricae 9g, Radix Saposhnikoviae 10g, Fructus Xanthii 9g, Herba Menthae 12g, Radix Glycyrrhizae 4g, Herba Asari 2g and Borneolum Syntheticum 0.8g; All the other are with embodiment 1.
Embodiment 3
Proportioning: Herba Centipedae 20g, Radix Astragali 18g, Rhizoma Atractylodis Macrocephalae (parched) 12g, Periostracum Cicadae 11g, Radix Angelicae Dahuricae 12g, Radix Saposhnikoviae 9g, Fructus Xanthii 12g, Herba Menthae 9g, Radix Glycyrrhizae 8g, Herba Asari 2g and Borneolum Syntheticum 1.5g; All the other are with embodiment 1.
Embodiment 4
Proportioning: Herba Centipedae 22g, Radix Astragali 18g, Rhizoma Atractylodis Macrocephalae (parched) 12g, Periostracum Cicadae 10g, Radix Angelicae Dahuricae 12g, Radix Saposhnikoviae 8g, Fructus Xanthii 12g, Herba Menthae 8g, Radix Glycyrrhizae 3g, Herba Asari 2.5g and Borneolum Syntheticum 0.8g; All the other are with embodiment 1.
Embodiment 5
Proportioning: Herba Centipedae 20g, Radix Astragali 16g, Rhizoma Atractylodis Macrocephalae (parched) 10g, Periostracum Cicadae 10g, Radix Angelicae Dahuricae 5g, Radix Saposhnikoviae 5g, Fructus Xanthii 15g, Herba Menthae 5g, Radix Glycyrrhizae 4g, Herba Asari 3.5g and Borneolum Syntheticum 0.1g; All the other are with embodiment 1.
Embodiment 6
Proportioning: Herba Centipedae 25g, Radix Astragali 14g, Rhizoma Atractylodis Macrocephalae (parched) 13g, Periostracum Cicadae 12g, Radix Angelicae Dahuricae 8g, Radix Saposhnikoviae 12g, Fructus Xanthii 9g, Herba Menthae 8g, Radix Glycyrrhizae 10g, Herba Asari 4g and Borneolum Syntheticum 0.8g; All the other are with embodiment 1.
Embodiment 7
Proportioning: Herba Centipedae 14g, Radix Astragali 25g, Rhizoma Atractylodis Macrocephalae (parched) 10g, Periostracum Cicadae 15g, Radix Angelicae Dahuricae 15g, Radix Saposhnikoviae 13g, Fructus Xanthii 7g, Herba Menthae 15g, Radix Glycyrrhizae 5g, Herba Asari 3g and Borneolum Syntheticum 2.0g; All the other are with embodiment 1.
Embodiment 8
Proportioning: Herba Centipedae 20g, Radix Astragali 14g, Rhizoma Atractylodis Macrocephalae (parched) 11g, Periostracum Cicadae 13g, Radix Angelicae Dahuricae 5g, Radix Saposhnikoviae 15g, Fructus Xanthii 12g, Herba Menthae 9g, sweet 3g, Herba Asari 1.5g and Borneolum Syntheticum 0.3g; All the other are with embodiment 1.
Embodiment 9
Proportioning: Herba Centipedae 18g, Radix Astragali 14g, Rhizoma Atractylodis Macrocephalae (parched) 8g, Periostracum Cicadae 11g, Radix Angelicae Dahuricae 5g, Radix Saposhnikoviae 5g, Fructus Xanthii 13g, Herba Menthae 8g, Radix Glycyrrhizae 8g, Herba Asari 2.5g and Borneolum Syntheticum 0.5g; All the other are with embodiment 1.
Embodiment 10
Proportioning: Herba Centipedae 22g, Radix Astragali 14g, Rhizoma Atractylodis Macrocephalae (parched) 15g, Periostracum Cicadae 10g, Radix Angelicae Dahuricae 5g, Radix Saposhnikoviae 10g, Fructus Xanthii 5g, Herba Menthae 12g, Radix Glycyrrhizae 6g, Herba Asari 3g and Borneolum Syntheticum 0.3g; All the other are with embodiment 1.
Claims (3)
1. the ultramicro powder Chinese medicine of a treatment of allergic rhinitis is characterized in that:
⑴ made by the Chinese medicine of following weight proportion
14～25 parts of Herba Centipedae, 14～25 parts of the Radixs Astragali, 8～15 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 8～15 parts of Periostracum Cicadaes, 5～15 parts of the Radixs Angelicae Dahuricae, 5～15 parts of Radix Saposhnikoviaes, 5～15 parts of Fructus Xanthii, 5～15 parts of Herba Menthaes, 1～10 part, Radix Glycyrrhizae, 0.1～2.0 part of 0.5～5 part of Herba Asari and Borneolum Syntheticum;
⑵ the preparation method of described ultramicro powder Chinese medicine is characterized in that comprising the steps
1. after the Chinese crude drug of above-mentioned dosage being cleaned, be ground into respectively the micropowders of particle diameter≤74～25 μ m;
2. pack respectively by each treatment by Chinese herbs dosage, standby;
3. each Chinese medicine micropowders mix homogeneously that will pack is respectively packed separately by seance dosage;
⑶ the application of described ultramicro powder Chinese medicine is characterized in that the application in the pharmaceutical preparation of preparation treatment of allergic rhinitis.
2. according to ultramicro powder Chinese medicine claimed in claim 1, it is characterized in that being made by the Chinese medicine of following weight proportion:
16～22 parts of Herba Centipedae, 16～22 parts of the Radixs Astragali, 10～13 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 10～13 parts of Periostracum Cicadaes, 12～15 parts of the Radixs Angelicae Dahuricae, 9～12 parts of Radix Saposhnikoviaes, 9～12 parts of Fructus Xanthii, 9～12 parts of Herba Menthaes, 4～8 parts, Radix Glycyrrhizae, 0.8～1.5 part of 1～3 part of Herba Asari and Borneolum Syntheticum.
3. according to ultramicro powder Chinese medicine claimed in claim 1, it is characterized in that being made by the Chinese medicine of following weight proportion:
18～20 parts of Herba Centipedae, 18～20 parts of the Radixs Astragali, 11～12 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 11～12 parts of Periostracum Cicadaes, 9～12 parts of the Radixs Angelicae Dahuricae, 8～10 parts of Radix Saposhnikoviaes, 7～9 parts of Fructus Xanthii, 5～8 parts of Herba Menthaes, 3～4 parts, Radix Glycyrrhizae, 1.5～2.0 parts of 2～2.5 parts of Herba Asaris and Borneolum Syntheticums.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310092177.4A CN103142693B (en) | 2013-03-20 | 2013-03-20 | Superfine powdery Chinese medicinal preparation for treating allergic rhinitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310092177.4A CN103142693B (en) | 2013-03-20 | 2013-03-20 | Superfine powdery Chinese medicinal preparation for treating allergic rhinitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103142693A true CN103142693A (en) | 2013-06-12 |
| CN103142693B CN103142693B (en) | 2014-10-01 |
Family
ID=48541202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310092177.4A Expired - Fee Related CN103142693B (en) | 2013-03-20 | 2013-03-20 | Superfine powdery Chinese medicinal preparation for treating allergic rhinitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103142693B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104472795A (en) * | 2014-11-26 | 2015-04-01 | 湖南中医药大学 | Immunity-improving health tea bag |
| CN105056087A (en) * | 2015-08-12 | 2015-11-18 | 彭刘平 | Traditional Chinese medicine composition for treating viral nasosinusitis |
| CN110477699A (en) * | 2019-09-10 | 2019-11-22 | 中优堂(上海)医疗管理有限公司 | A kind of anti-inflammatory medicine-filled pillow for controlling rhinitis for adjusting immunosupress allergy |
| CN112023014A (en) * | 2020-09-29 | 2020-12-04 | 江西中医药大学 | Traditional Chinese medicine incense for relieving allergic rhinitis and preparation process thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1480189A (en) * | 2003-07-10 | 2004-03-10 | 姜延德 | Medication for treating rhinitis |
-
2013
- 2013-03-20 CN CN201310092177.4A patent/CN103142693B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1480189A (en) * | 2003-07-10 | 2004-03-10 | 姜延德 | Medication for treating rhinitis |
Non-Patent Citations (3)
| Title |
|---|
| 杜英杰等: "中医治疗过敏性鼻炎研究进展", 《实用中医药杂志》 * |
| 温俊达等: "三七等9种中药超微粉的粒径研究", 《时珍国医国药》 * |
| 蒋贵云: "玉屏风散加减治疗变应性鼻炎58例", 《国际中医中药杂志》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104472795A (en) * | 2014-11-26 | 2015-04-01 | 湖南中医药大学 | Immunity-improving health tea bag |
| CN105056087A (en) * | 2015-08-12 | 2015-11-18 | 彭刘平 | Traditional Chinese medicine composition for treating viral nasosinusitis |
| CN110477699A (en) * | 2019-09-10 | 2019-11-22 | 中优堂(上海)医疗管理有限公司 | A kind of anti-inflammatory medicine-filled pillow for controlling rhinitis for adjusting immunosupress allergy |
| CN112023014A (en) * | 2020-09-29 | 2020-12-04 | 江西中医药大学 | Traditional Chinese medicine incense for relieving allergic rhinitis and preparation process thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103142693B (en) | 2014-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102028812B (en) | Chinese medicinal preparation for treating allergic rhinitis, allergic asthma and urticaria and preparation method thereof | |
| CN103142693B (en) | Superfine powdery Chinese medicinal preparation for treating allergic rhinitis | |
| CN103463500B (en) | Medicament for treating cerebral hemorrhage | |
| CN104189554A (en) | Traditional Chinese medicine patch for treating pediatric hot asthma and preparation method of traditional Chinese medicine patch | |
| CN102579687B (en) | Nasal cavity Chinese medicinal washing fluid for rhinitis | |
| CN102091195B (en) | Medicament for treating snore and sleep apnea syndrome | |
| CN103191331B (en) | Traditional Chinese medicine composition for treating bronchial asthma in remission stage | |
| CN102225193B (en) | Traditional Chinese medicine composition for controlling recurrent respiratory tract infection of children | |
| CN107812084A (en) | A kind of Chinese medicine composition for treating allergic rhinitis and its preparation and application | |
| CN101129755A (en) | Orally taken traditional Chinese medicine composition for treating asthma | |
| CN106620205A (en) | Externally-used traditional Chinese medicine for foot bath to treat pediatric fever | |
| CN103301373B (en) | Pharmaceutical composition for treating postpartum perineal mucosal lesions | |
| CN101869653A (en) | Chinese medicinal preparation for treating chronic nasosinusitis and preparation method thereof | |
| CN104857414A (en) | Medicine composite for treating chronic simple rhinitis | |
| CN105106601A (en) | Medicinal preparation for treating acute nasopharyngitis | |
| CN104474173B (en) | A kind of medicine for treating facioplegia | |
| CN102697844B (en) | Chinese herbal medicine nasal agent | |
| CN102552686A (en) | Traditional Chinese medicinal aerosol for treating chronic pharyngitis in clinical care | |
| CN102698073A (en) | Traditional Chinese medicine extract for treating allergic rhinitis | |
| CN105056087A (en) | Traditional Chinese medicine composition for treating viral nasosinusitis | |
| CN105106814A (en) | Traditional Chinese medicine combination for treating viral rhinitis | |
| CN105362548A (en) | Traditional Chinese medicine for treating allergic asthma | |
| CN105327140A (en) | Traditional Chinese medicine preparation with heart nourishing function | |
| CN102824624A (en) | Traditional Chinese medicine for treating bronchitis | |
| CN104758710A (en) | External application traditional Chinese medicine used for treating allergic rhinitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141001 Termination date: 20160320 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |